Nonin Medical, Inc. Announces FDA 510(k) Clearance Expanded Labeling for Onyx® Vantage 9590 Professional Fingertip Pulse Oximeter at ATS Annual Meeting

Onyx® Vantage first and only fingertip pulse oximeter with accuracy claims for expanded use on thumbs and toes

May 21, 2012, 14:18 ET from Nonin Medical, Inc.

MINNEAPOLIS, May 21, 2012 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced commercial release with expanded labeling claims for its Onyx® Vantage 9590 professional fingertip pulse oximeter. The new labeling allows the Onyx Vantage to be used on thumbs and toes – an addition to a previous indication for fingertips – on pediatric through adult patients whose digit diameters range from 0.3 inches to 1.0 inches. Nonin Medical made the announcement at the American Thoracic Society (ATS) 2012 Annual Meeting in San Francisco. The Onyx Vantage accurately captures oxygen saturation (SpO2) and pulse rate measurements even in the presence of low perfusion and dark skin pigmentation. It is the first and only fingertip pulse oximeter with accuracy claims for expanded use on thumbs and toes.

"Nonin's Onyx brand of professional finger pulse oximeters is already proven accurate in the widest range of patients and settings," said Kevin McGowan, vice president, global sales, for Nonin Medical. "With this expanded indication, clinicians will now be able to use Nonin's newest professional pulse oximeter, the Onyx Vantage 9590, on fingers, thumbs or toes. This gives them even more flexibility to obtain accurate readings on a wide range of patients from pediatrics through adults.

"No longer will clinicians have to trade flexibility for peace of mind," McGowan added. "That's because, regardless of which digit they use, they can be assured that they are getting accurate readings for improved decision making that may lead to earlier intervention and better outcomes."

The Onyx Vantage finger pulse oximeter is engineered with Nonin Medical's clinically proven PureSAT™ pulse oximetry technology – the same accurate technology used in its full line of oximeters. Peer-reviewed articles about Nonin's proven accuracy can be found online at

The Onyx Vantage 9590, along with Nonin's complete line of professional wrist-worn, handheld and tabletop pulse oximeters, sensors and capnographs, can be viewed at Nonin Medical Booth #516, Moscone Center, San Francisco, during ATS Annual Meeting exhibit hours on Monday, May 21, from 10am-3pm, and Tuesday, May 22, from 10am-3pm.

About Nonin Medical, Inc.
Nonin Medical, Inc. invented fingertip and wireless fingertip pulse oximetry and is a leader in noninvasive medical monitoring. Headquartered in Minneapolis, Minn., USA, with an additional service center in Hudiksvall, Sweden, Nonin Medical designs and manufactures noninvasive pulse oximeters, regional oximeters, capnographs, sensors, software and accessories globally. The company sells its products to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide.

As a founding member of the Continua Alliance and a Bluetooth SIG CES Award winner, Nonin Medical is dedicated to developing low power, interoperable technology to reduce healthcare costs and improve quality of life. Since certifying the world's first Continua™-certified product in 2009, the company continues to lead the industry in simplifying the exchange of healthcare information while driving global connectivity standards and adding interoperable solutions across its product line. For more information, visit

SOURCE Nonin Medical, Inc.